Clinical trial
The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France
NCT07211126 is registered in ClinicalTrials.gov with Tandem Diabetes Care, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France
- Lead sponsor
- Tandem Diabetes Care, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 3, 2026
- Completion date
- December 31, 2027
- Enrollment
- 350 (estimated)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.